Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NEVIRAPINE
- Letermovir in ART-treated HIV-infected Persons
- Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)
- DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women
- Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
- HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
- Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana
- Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors
- Antiretroviral Regime for Viral Eradication in Newborns
- Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial
- Early Infant HIV Treatment in Botswana
- A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation
- Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects
- Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
- Multiple Dose BE Study With Nevirapine 400mg PR Tablets
- Pharmacokinetic Properties of Nevirapine Extended Release Tablets When Administered Orally in Healthy Male Volunteers
- Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects
- Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens
- Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®
- Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS
- Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression
- Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy Males
- Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers
- Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients
- Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients
- Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine
- Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults
- Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients
- Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women
- First-Line Treatment for HIV-2
- Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission
- Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Virem
- Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir
- A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy
- Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB
- A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy
- Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting
- Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
- Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
- Abacavir and Lamivudine PK in Children
- Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
- Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
- The Rilpivirine Cerebrospinal-fluid (CSF) Study
- Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
- Bioequivalence Study of Pediatric Formulations to Treat HIV Infection
- The Effect of Intermittent Rifampicin on Raltegravir
- Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
- Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
- Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
- Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight
- Single Dose Truvada in HIV-negative Men and Women
- Influence of Nevirapine on HCV Viral Load
- Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
- Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
- Depot Contraception With and Without Lopinavir/Ritonavir
- Study to Improve Survival Among HIV-Exposed Infants in Botswana
- Safety Study of Raltegravir in HIV/HCV Co-infected Patients
- PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial
- The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance
- A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
- Treatment Options for Protease Inhibitor-exposed Children
- Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
- Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
- Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
- Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity
- A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
- Triomune Bioequivalence With Innovators
- Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
- Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
- TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP)
- A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
- Dose Reduction of Lopinavir in Children
- Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania
- Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
- Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
- Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
- Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)
- Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients
- Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125
- Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults
- Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors
- Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART
- Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
- VENICE Study Nevirapine Full Dose/Dose Escalation
- Durability of Nevirapine-Based Antiretroviral Regimen
- Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
- Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
- Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics
- Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients
- Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
- Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
- Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort
- Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
- VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients
- Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)
- The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
- A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
- Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
- Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)
- Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
- Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy
- Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
- Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
- Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
- Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only
- Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients
- Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand
- Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia
- Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand
- Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults
- HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT
- Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients
- Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)
- Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression
- A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine
- Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women
- Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients
- To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir
- Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
- Structured Treatment Interruptions in Chronic HIV Infection
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
- Case-Control Viramune (Nevirapine) Toxicogenomics Study
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
- Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV
- Pharmacokinetics Study on Nevirapine Resistance in Tanzania
- Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients
- Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults
- Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients
- Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
- A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
- Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children
- Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities
- When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)
- Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP
- Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
- Prevention of Milk-Borne Transmission of HIV-1C in Botswana
- HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
- ARVs to Prevent Breastmilk HIV:Viral and Immune Responses
- ATV/Ritonavir Nevirapine Interaction (USPAC)
- Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression
- Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)
- A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding
- An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects
- A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
- A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)
- Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV
- NRTI-Sparing Pilot Study
- One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine
- Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
- 2NN & CHARM Long-Term Follow-up Study
- Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
- MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)
- Pediatric Nevirapine Resistance Study
- Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
- Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth
- Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
- Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy
- Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
- NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission
- Three Month Course of Anti-HIV Medications for People Recently Infected With HIV
- Strategies for Delivering Anti-HIV Therapy in South Africa
- Preventing Sexual Transmission of HIV With Anti-HIV Drugs
- Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
- Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV
- Daily Nevirapine to Prevent Mother to Infant Transmission of HIV
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
- Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
- Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
- Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
- Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
- Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
- Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women
- Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
- Capravirine to Treat Children With HIV Infection
- Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns
- The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months
- Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs
- Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
- A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
- A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
- A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
- The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
- A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
- The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
- The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
- The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
- The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease
- A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Month
- An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
- An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease
- A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine
- Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
- A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants
- A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children
- A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses
- A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
- Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
- A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients
- Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs
- Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease
- The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
- A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies
- A Study to Compare Two Different Anti-HIV Drug Regimens
- A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
- A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment
- A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
- A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
- Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
- A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
- A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease
- A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers
- A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
- A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
- An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3
- An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
- A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
Clinical trials list
click for details